RxDoctor Payments Data
★ My doctorsLook up a doctor →

Hafiz Kassam, MD

Orthopaedic Surgery · Newport Beach, CANPI 1306371059

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 77.3% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $573,179, more than ten times the $20,074 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$914,176in general payments, 2019–2025

Across 762 payments — averaging $1199.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$707K
  • Encore Medical, LP$52K
  • Catalyst Orthoscience$42K
  • Medical Device Business Services, Inc.$38K
  • Smith+Nephew$30K
  • Arthrex$12K
  • plus $34K from 14 others
$174,169in research payments, 2019–2025

Across 16 payments — averaging $10,886 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$93K
  • Innovation Technologies Inc$81K

What the payments were for

  • Consulting fees$530,22758%
  • Speaking & faculty fees$29,3483%
  • Travel & lodging$56,9446%
  • Food & beverage$23,9353%
  • Education$273,72230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet421$706,966
Encore Medical, LP38$51,767
Catalyst Orthoscience35$42,326
Medical Device Business Services, Inc.34$37,833
Smith+Nephew45$29,648
Arthrex77$12,023
Depuy Synthes Products, Inc.10$8,698
Stryker54$8,175
Geistlich Pharma, North America, Inc.7$5,009
Sequoia Surgical, Inc.10$4,004
FX Shoulder Solutions, Inc4$2,425
Exactech, Inc.5$2,379
Saxum Surgical, Inc.6$1,419
Shoulder Innovations, Inc.2$523
Johnson & Johnson7$493
Linvatec Corporation3$233
Medacta USA, Inc.1$105
Cornerstone Medical Associates, Inc.1$73
Lifenet Health1$52
Pacira Pharmaceuticals Incorporated1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$914,176 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$544,303
Medicare patients
680
Services billed
3,003

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen209$1,693
Oxycodone Hcl182$852
Meloxicam144$451
Gabapentin93$324
Doxycycline Hyclate18$279
Baclofen28$151
Amoxicillin40$60
Tramadol Hcl13$13

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Newport Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →